B. Sc., College of Pharmacy, Catholic University of Daegu
2010 – 2012
M. Sc., College of Pharmacy, Catholic University of Daegu
2012 – 2015
Ph. D., School of Pharmacy, Sungkyunkwan University
2012 – 2015
Researcher, Pharmaceutical research institute, Sungkyunkwan University
2015 – 2017
Senior researcher, Pharmaceutical research institute, Sungkyunkwan University
2015 – 2017
Post doctoral associate, School of Pharmacy, Sungkyunkwan University
2016 – 2017
Adjunct professor, School of Pharmacy, Sungkyunkwan University
2017 – 2018
Post doctoral associate, College of Pharmacy, University of Florida
논문 1
Oh HS, Park EJ, Lee TS, An Y, Kim TH, Shin S, Shin BS. Pharmacokinetics of Lixisenatide, a GLP-1 Receptor Agonist, Determined by a Novel Liquid Chromatography–Tandem Mass Spectrometry Analysis in Rats. Separations. 2023;10(5).
논문 2
Oh HS, Choi M, Lee TS, An Y, Park EJ, Kim TH, Shin S, Shin BS. Pharmacokinetics and brain distribution of the therapeutic peptide liraglutide by a novel LC–MS/MS analysis. Journal of Analytical Science and Technology. 2023;14(1).
논문 3
Lee TS, Park EJ, Choi M, Oh HS, An Y, Kim T, Kim TH, Shin BS, Shin S. Novel LC-MS/MS analysis of the GLP-1 analog semaglutide with its application to pharmacokinetics and brain distribution studies in rats. J Chromatogr B Analyt Technol Biomed Life Sci. 2023;1221:123688.
논문 4
Kim W, Kim E, Lee J, Song CH, Jung W, Shin S, Kim KB, Shin BS, Kim TH. Development of an LC-MS/MS Assay and Toxicokinetic Characterization of Hexamethylenetetramine in Rats. Toxics. 2023;11(4).
논문 5
Kim JY, Kim TH, Kim E, Choi DH. Developmental strategy for swellable/erodible matrix tablet of mirabegron: quality by design approach with various geometric properties and pharmacokinetic evaluation. Journal of Pharmaceutical Investigation. 2023;53(6):881-894.
논문 6
Kim J, Kim TH, Choi J, Nam K, Shin BS, Shin S. Novel modeling approach integrating population pharmacokinetics and interspecies scaling to predict human pharmacokinetics of the new anti-tuberculosis agent telacebec (Q203). Biomed Pharmacother. 2023;167:115441.
논문 7
Kim E, Jang E, Jung W, Kim W, Lee J, Choi DH, Shin BS, Shin S, Kim TH. Establishment of an LC-MS/MS method for quantification of lifitegrast in rabbit plasma and ocular tissues and its application to pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci. 2023;1229:123892.
논문 8
Yoon H, Kim TH, Lee BC, Lee B, Kim P, Shin BS, Choi J. Comparison of the exposure assessment of di(2-ethylhexyl) phthalate between the PBPK model-based reverse dosimetry and scenario-based analysis: A Korean general population study. Chemosphere. 2022;294:133549.
논문 9
Kim J, Choi J, Kang H, Ahn J, Hutchings J, Niekerk CV, Kim J, Jeon Y, Nam K, Kim TH, Shin BS, Shin S. Safety, Tolerability, Pharmacokinetics, and Metabolism of Telacebec (Q203) for the Treatment of Tuberculosis: a Randomized, Placebo-Controlled, Multiple Ascending Dose Phase 1B Trial. Antimicrob Agents Chemother. 2023;67(1):e0112322.
논문 10
Tait JR, Bilal H, Rogers KE, Lang Y, Kim TH, Zhou J, Wallis SC, Bulitta JB, Kirkpatrick CMJ, Paterson DL, Lipman J, Bergen PJ, Roberts JA, Nation RL, Landersdorfer CB. Effect of Different Piperacillin-Tazobactam Dosage Regimens on Synergy of the Combination with Tobramycin against Pseudomonas aeruginosa for the Pharmacokinetics of Critically Ill Patients in a Dynamic Infection Model. Antibiotics (Basel). 2022;11(1).
논문 11
Song CH, Kim K, Kang E, Jeong B, Lee MS, Jung J, Kim TH, Shin S, Shin BS. Determination of pharmacokinetics and tissue distribution of a novel lutetium-labeled PSMA-targeted ligand, (177)Lu-DOTA-PSMA-GUL, in rats by using LC-MS/MS. Sci Rep. 2022;12(1):15452.
논문 12
Park HJ, Choi G, Ha S, Kim Y, Choi MJ, Kim M, Islam MK, Chang Y, Kwon TJ, Kim D, Jang E, Kim TH, Chang SJ, Kim YH. MBP-11901 Inhibits Tumor Growth of Hepatocellular Carcinoma through Multitargeted Inhibition of Receptor Tyrosine Kinases. Cancers (Basel). 2022;14(8).
논문 13
Oh HS, Kim T, Gu DH, Lee TS, Kim TH, Shin S, Shin BS. Pharmacokinetics of Nafamostat, a Potent Serine Protease Inhibitor, by a Novel LC-MS/MS Analysis. Molecules. 2022;27(6).
논문 14
Lim JY, Kim TH, Song CH, Kim DH, Shin BS, Shin S. Novel extended IVIVC combined with DoE to predict pharmacokinetics from formulation compositions. J Control Release. 2022;343:443-456.
논문 15
Lee DY, Shin S, Kim TH, Shin BS. Establishment of Level a In Vitro-In Vivo Correlation (IVIVC) via Extended DoE-IVIVC Model: A Donepezil Case Study. Pharmaceutics. 2022;14(6).
논문 16
Jung W, Seok SH, Shin S, Ryu SH, Kim KB, Shin BS, Kim TH. Toxicokinetics, Percutaneous Absorption and Tissue Distribution of Benzophenone-3, an UV Filtering Agent, in Rats. Toxics. 2022;10(11).
논문 17
Tait JR, Bilal H, Kim TH, Oh A, Peleg AY, Boyce JD, Oliver A, Bergen PJ, Nation RL, Landersdorfer CB. Pharmacodynamics of ceftazidime plus tobramycin combination dosage regimens against hypermutable Pseudomonas aeruginosa isolates at simulated epithelial lining fluid concentrations in a dynamic in vitro infection model. J Glob Antimicrob Resist. 2021;26:55-63.
논문 18
Seok SH, Ha J-M, Kim TH, Kim G-W, Kim BH, Lee DW, Choi M-S, Lee S-H, Kim J-Y, Park E-S. Effect of gastric residence time on the oral absorption of rebamipide sustained-release tablets in beagle dogs. Journal of Pharmaceutical Investigation. 2021;51(6):759-766.
논문 19
Lee JB, Zang X, Zgair A, Ooi TQ, Foley DW, Voronin G, Kagan L, Soukarieh F, Gao R, Shao H, Soh WT, Kim TH, Kim MG, Yun HY, Wilson AJ, Fischer PM, Gershkovich P. Administration in fed state but not controlled release in the colon increases oral bioavailability of DF030263, a promising drug candidate for chronic lymphocytic leukemia. Eur J Pharm Biopharm. 2021;165:106-112.
논문 20
Shin S, Kim TH, Lee DY, Chung SE, Lee JB, Kim DH, Shin BS. Development of a Population Pharmacokinetics-Based in vitro-in vivo Correlation Model for Drugs with Site-Dependent Absorption: the Acyclovir Case Study. AAPS J. 2020;22(2):27.
논문 21
Lee JB, Zhou S, Chiang M, Zang X, Kim TH, Kagan L. Interspecies prediction of pharmacokinetics and tissue distribution of doxorubicin by physiologically-based pharmacokinetic modeling. Biopharm Drug Dispos. 2020;41(4-5):192-205.
논문 22
Kim TH, Tao X, Moya B, Jiao Y, Basso KB, Zhou J, Lang Y, Sutaria DS, Zavascki AP, Barth AL, Reeve SM, Schweizer HP, Deveson Lucas D, Boyce JD, Bonomo RA, Lee RE, Shin BS, Louie A, Drusano GL, Bulitta JB. Novel Cassette Assay To Quantify the Outer Membrane Permeability of Five beta-Lactams Simultaneously in Carbapenem-Resistant Klebsiella pneumoniae and Enterobacter cloacae. mBio. 2020;11(1).
논문 23
Thapa SK, Upadhyay M, Kim TH, Shin S, Park SJ, Shin BS. Liquid Chromatography-Tandem Mass Spectrometry of Desoxo-Narchinol a and Its Pharmacokinetics and Oral Bioavailability in Rats and Mice. Molecules. 2019;24(11).
논문 24
Shin S, Kim TH, Jeong SW, Chung SE, Lee DY, Kim DH, Shin BS. Development of a gastroretentive delivery system for acyclovir by 3D printing technology and its in vivo pharmacokinetic evaluation in Beagle dogs. PLoS One. 2019;14(5):e0216875.
논문 25
Shin S, Jeong HM, Chung SE, Kim TH, Thapa SK, Lee DY, Song CH, Lim JY, Cho SM, Nam KY, Kang WH, Choi YW, Shin BS. Simultaneous analysis of acetylcarnitine, proline, hydroxyproline, citrulline, and arginine as potential plasma biomarkers to evaluate NSAIDs-induced gastric injury by liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal. 2019;165:101-111.
논문 26
Lee KW, Kim TH, Lee JB, Kim KS, Park JB, Gershkovich P, Yoo SD, Shin S, Shin BS, Kim SJ. Reduced variability in tacrolimus pharmacokinetics following intramuscular injection compared to oral administration in cynomolgus monkeys: Investigating optimal dosing regimens. J Pharmacol Sci. 2019;139(2):65-71.
논문 27
Lee JB, Radhi M, Cipolla E, Gandhi RD, Sarmad S, Zgair A, Kim TH, Feng W, Qin C, Adrower C, Ortori CA, Barrett DA, Kagan L, Fischer PM, de Moor CH, Gershkovich P. A novel nucleoside rescue metabolic pathway may be responsible for therapeutic effect of orally administered cordycepin. Sci Rep. 2019;9(1):15760.
논문 28
Lee JB, Kim TH, Feng W, Choi HG, Zgair A, Shin S, Yoo SD, Gershkovich P, Shin BS. Quantitative Prediction of Oral Bioavailability of a Lipophilic Antineoplastic Drug Bexarotene Administered in Lipidic Formulation Using a Combined In Vitro Lipolysis/Microsomal Metabolism Approach. J Pharm Sci. 2019;108(2):1047-1052.
논문 29
Kim TH, Shin S, Jeong SW, Lee JB, Shin BS. Physiologically Relevant In Vitro-In Vivo Correlation (IVIVC) Approach for Sildenafil with Site-Dependent Dissolution. Pharmaceutics. 2019;11(6).
논문 30
Kim TH, Bulitta JB, Kim DH, Shin S, Shin BS. Novel extended in vitro-in vivo correlation model for the development of extended-release formulations for baclofen: From formulation composition to in vivo pharmacokinetics. Int J Pharm. 2019;556:276-286.
논문 31
Bilal H, Bergen PJ, Kim TH, Chung SE, Peleg AY, Oliver A, Nation RL, Landersdorfer CB. Synergistic Meropenem-Tobramycin Combination Dosage Regimens against Clinical Hypermutable Pseudomonas aeruginosa at Simulated Epithelial Lining Fluid Concentrations in a Dynamic Biofilm Model. Antimicrob Agents Chemother. 2019;63(11).
논문 32
Jiao Y, Moya B, Chen MJ, Zavascki AP, Tsai H, Tao X, Sutaria DS, Louie A, Boyce JD, Deveson Lucas D, Kim TH, Tsuji BT, Bonomo RA, Drusano GL, Bulitta JB. Comparable Efficacy and Better Safety of Double beta-Lactam Combination Therapy versus beta‑Lactam plus Aminoglycoside in Gram-Negative Bacteria in Randomized, Controlled Trials. Antimicrob Agents Chemother. 2019;63(7).
논문 33
Bilal H, Bergen PJ, Kim TH, Chung SE, Peleg AY, Oliver A, Nation RL, Landersdorfer CB. Synergistic Meropenem-Tobramycin Combination Dosage Regimens against Clinical Hypermutable Pseudomonas aeruginosa at Simulated Epithelial Lining Fluid Concentrations in a Dynamic Biofilm Model. Antimicrob Agents Chemother. 2019;63(11).
논문 34
Weon KY, Kim MG, Shin S, Kim TH, Joo SH, Ma E, Jeong SW, Yoo SD, Youn YS, Shin BS. Alterations of Gefitinib Pharmacokinetics by Co-administration of Herbal Medications in Rats. Chin J Integr Med. 2018;24(6):460-466.
논문 35
Sutaria DS, Moya B, Green KB, Kim TH, Tao X, Jiao Y, Louie A, Drusano GL, Bulitta JB. First Penicillin-Binding Protein Occupancy Patterns of beta-Lactams and beta-Lactamase Inhibitors in Klebsiella pneumoniae. Antimicrob Agents Chemother. 2018;62(6).
논문 36
Pires de Mello CP, Tao X, Kim TH, Vicchiarelli M, Bulitta JB, Kaushik A, Brown AN. Clinical Regimens of Favipiravir Inhibit Zika Virus Replication in the Hollow-Fiber Infection Model. Antimicrob Agents Chemother. 2018;62(9).
논문 37
Pires de Mello CP, Tao X, Kim TH, Bulitta JB, Rodriquez JL, Pomeroy JJ, Brown AN. Zika Virus Replication Is Substantially Inhibited by Novel Favipiravir and Interferon Alpha Combination Regimens. Antimicrob Agents Chemother. 2018;62(1).
논문 38
Lee JB, Zgair A, Malec J, Kim TH, Kim MG, Ali J, Qin C, Feng W, Chiang M, Gao X, Voronin G, Garces AE, Lau CL, Chan TH, Hume A, McIntosh TM, Soukarieh F, Al-Hayali M, Cipolla E, Collins HM, Heery DM, Shin BS, Yoo SD, Kagan L, Stocks MJ, Bradshaw TD, Fischer PM, Gershkovich P. Lipophilic activated ester prodrug approach for drug delivery to the intestinal lymphatic system. J Control Release. 2018;286:10-19.
논문 39
Landersdorfer CB, Yadav R, Rogers KE, Kim TH, Shin BS, Boyce JD, Nation RL, Bulitta JB. Combating Carbapenem-Resistant Acinetobacter baumannii by an Optimized Imipenem-plus-Tobramycin Dosage Regimen: Prospective Validation via Hollow-Fiber Infection and Mathematical Modeling. Antimicrob Agents Chemother. 2018;62(4).
논문 40
Landersdorfer CB, Rees VE, Yadav R, Rogers KE, Kim TH, Bergen PJ, Cheah SE, Boyce JD, Peleg AY, Oliver A, Shin BS, Nation RL, Bulitta JB. Optimization of a Meropenem-Tobramycin Combination Dosage Regimen against Hypermutable and Nonhypermutable Pseudomonas aeruginosa via Mechanism-Based Modeling and the Hollow-Fiber Infection Model. Antimicrob Agents Chemother. 2018;62(4).
논문 41
Kim TH, Thapa SK, Lee DY, Chung SE, Lim JY, Jeong HM, Song CH, Choi YW, Cho SM, Nam KY, Kang WH, Shin S, Shin BS. Pharmacokinetics and Anti-Gastric Ulceration Activity of Oral Administration of Aceclofenac and Esomeprazole in Rats. Pharmaceutics. 2018;10(3).
논문 42
Kim TH, Shin S, Yoo SD, Shin BS. Effects of Phytochemical P-Glycoprotein Modulators on the Pharmacokinetics and Tissue Distribution of Doxorubicin in Mice. Molecules. 2018;23(2).
논문 43
Kim TH, Paik SH, Chi YH, Bulitta JB, Lee DY, Lim JY, Chung SE, Song CH, Jeong HM, Shin S, Shin BS. Regional Absorption of Fimasartan in the Gastrointestinal Tract by an Improved in situ Absorption Method in Rats. Pharmaceutics. 2018;10(4).
논문 44
Jiao Y, Kim TH, Tao X, Kinzig M, Landersdorfer CB, Drescher SK, Sutaria DS, Moya B, Holzgrabe U, Sorgel F, Bulitta JB. First population pharmacokinetic analysis showing increased quinolone metabolite formation and clearance in patients with cystic fibrosis compared to healthy volunteers. Eur J Pharm Sci. 2018;123:416-428.
논문 45
Thao LQ, Lee C, Kim B, Lee S, Kim TH, Kim JO, Lee ES, Oh KT, Choi HG, Yoo SD, Youn YS. Doxorubicin and paclitaxel co-bound lactosylated albumin nanoparticles having targetability to hepatocellular carcinoma. Colloids Surf B Biointerfaces. 2017;152:183-191.
논문 46
Lee JB, Zgair A, Taha DA, Zang X, Kagan L, Kim TH, Kim MG, Yun HY, Fischer PM, Gershkovich P. Quantitative analysis of lab-to-lab variability in Caco-2 permeability assays. Eur J Pharm Biopharm. 2017;114:38-42.
논문 47
Lee JB, Zgair A, Kim TH, Kim MG, Yoo SD, Fischer PM, Gershkovich P. Simple and sensitive HPLC-UV method for determination of bexarotene in rat plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2017;1040:73-80.
논문 48
Kim TH, Shin S, Shin JC, Bulitta JB, Weon KY, Yoo SD, Park GY, Jeong SW, Kwon DR, Min BS, Woo MH, Shin BS. Effect of Sipjeondaebo-Tang on the Pharmacokinetics of S-1, an Anticancer Agent, in Rats Evaluated by Population Pharmacokinetic Modeling. Molecules. 2017;22(9).
논문 49
Kim TH, Shin S, Shin BS. Model-based drug development: application of modeling and simulation in drug development. Journal of Pharmaceutical Investigation. 2017;48(4):431-441.
논문 50
Kim TH, Shin S, Kim S, Bulitta JB, Weon KY, Joo SH, Ma E, Yoo SD, Park GY, Kwon DR, Jeong SW, Lee DY, Shin BS. Alterations in Pharmacokinetics of Gemcitabine and Erlotinib by Concurrent Administration of Hyangsayukgunja-Tang, a Gastroprotective Herbal Medicine. Molecules. 2017;22(9).
논문 51
Kim TH, Shin S, Bulitta JB, Youn YS, Yoo SD, Shin BS. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation. Mol Pharm. 2017;14(1):53-65.
논문 52
Bulitta JB, Paik SH, Chi YH, Kim TH, Shin S, Landersdorfer CB, Jiao Y, Yadav R, Shin BS. Characterizing the time-course of antihypertensive activity and optimal dose range of fimasartan via mechanism-based population modeling. Eur J Pharm Sci. 2017;107:32-44.
논문 53
Kim TH, Kim MG, Shin S, Chi YH, Paik SH, Lee JH, Yoo SD, Youn YS, Bulitta JB, Joo SH, Jeong SW, Weon KY, Shin BS. Placental transfer and mammary excretion of a novel angiotensin receptor blocker fimasartan in rats. BMC Pharmacol Toxicol. 2016;17(1):35.
논문 54
Lee JB, Son SH, Park MC, Kim TH, Kim MG, Yoo SD, Kim S. A novel in vitro permeability assay using three-dimensional cell culture system. J Biotechnol. 2015;205:93-100.
논문 55
Lee JB, Shin B, Lee SH, Lee BY, Kim TH, Kim MG, Yoo SD. Exposure assessment of epidermal growth factor to various tissues in mice after intravenous and subcutaneous administration. J Pharm Pharmacol. 2015;67(11):1519-1527.
논문 56
Kim TH, Yoo SD, Lee HS, Lee KM, Seok SH, Kim MG, Jung BH, Kim MG, Shin BS. In vivo absorption and disposition of alpha-cedrene, a sesquiterpene constituent of cedarwood oil, in female and male rats. Drug Metab Pharmacokinet. 2015;30(2):168-173.
논문 57
Kim TH, Shin S, Landersdorfer CB, Chi YH, Paik SH, Myung J, Yadav R, Horkovics-Kovats S, Bulitta JB, Shin BS. Population Pharmacokinetic Modeling of the Enterohepatic Recirculation of Fimasartan in Rats, Dogs, and Humans. AAPS J. 2015;17(5):1210-1223.
논문 58
Kim TH, Shin S, Kim KB, Seo WS, Shin JC, Choi JH, Weon KY, Joo SH, Jeong SW, Shin BS. Determination of acrylamide and glycidamide in various biological matrices by liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic study. Talanta. 2015;131:46-54.
논문 59
Kim TH, Seok SH, Kim KB, Shin BS, Lee JP, Choi YK, Kim MG, Kim MK, Kim SM, Yoo SD. LC-APCI-MS/MS Quantification and Topical Bioavailability of Chloroacetamide in Rats. J Chromatogr Sci. 2015;53(7):1100-1106.
논문 60
Kim TH, Kim MG, Kim MG, Shin BS, Kim KB, Lee JB, Paik SH, Yoo SD. Simultaneous determination of phenoxyethanol and its major metabolite, phenoxyacetic acid, in rat biological matrices by LC-MS/MS with polarity switching: Application to ADME studies. Talanta. 2015;144:29-38.
논문 61
Kim MG, Kim TH, Shin BS, Lee YB, Lee JB, Choi HG, Lee Y, Yoo SD. Sensitive liquid chromatography-tandem mass spectrometry method for the simultaneous determination of benzyl butyl phthalate and its metabolites, monobenzyl phthalate and monobutyl phthalate, in rat plasma, urine, and various tissues collected from a toxicokinetic study. Anal Bioanal Chem. 2015;407(24):7391-7400.
논문 62
Kim MG, Kim TH, Shin BS, Kim MG, Seok SH, Kim KB, Lee JB, Choi HG, Lee YS, Yoo SD. A sensitive LC-ESI-MS/MS method for the quantification of avobenzone in rat plasma and skin layers: Application to a topical administration study. J Chromatogr B Analyt Technol Biomed Life Sci. 2015;1003:41-46.
논문 63
Shin BS, Yoo SD, Kim TH, Bulitta JB, Landersdorfer CB, Shin JC, Choi JH, Weon KY, Joo SH, Shin S. Quantitative determination of absorption and first-pass metabolism of apicidin, a potent histone deacetylase inhibitor. Drug Metab Dispos. 2014;42(6):974-982.
논문 64
Kim TH, Shin S, Bashir M, Chi YH, Paik SH, Lee JH, Choi HJ, Choi JH, Yoo SD, Bulitta JB, Ma E, Joo SH, Shin BS. Pharmacokinetics and metabolite profiling of fimasartan, a novel antihypertensive agent, in rats. Xenobiotica. 2014;44(10):913-925.
논문 65
Kim TH, Shin BS, Kim KB, Shin SW, Seok SH, Kim MK, Kim EJ, Kim D, Kim MG, Park ES, Kim JY, Yoo SD. Percutaneous absorption, disposition, and exposure assessment of homosalate, a UV filtering agent, in rats. J Toxicol Environ Health A. 2014;77(4):202-213.
논문 66
Kim TH, Park GY, Shin S, Kwon DR, Seo WS, Shin JC, Choi JH, Joo SH, Weon KY, Min BS, Baek KM, Upadhyay M, Zhao BT, Woo MH, Kwon SH, Shin BS. Pharmacokinetic alteration of baclofen by multiple oral administration of herbal medicines in rats. Evid Based Complement Alternat Med. 2014;2014:402126.
논문 67
Kim TH, Shin S, Shin JC, Choi JH, Seo WS, Park GY, Kwon DR, Yoo SD, Lee AR, Joo SH, Min BS, Yoo WY, Shin BS. Liquid chromatography-tandem mass spectrometry determination of baclofen in various biological samples and application to a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci. 2013;938:43-50.
논문 68
Hong JY, Lee BH, Kim TH, Hong J, Lee KM, Yoo SD, Lee HS. GC-MS/MS method for the quantification of alpha-cedrene in rat plasma and its pharmacokinetic application. J Sep Sci. 2013;36(21-22):3558-3562.
논문 69
Choi Y, Shin BS, Kim MG, Shin SW, Choo HW, Kim TH, Jang HC, Yoo SD. Micro-sample analysis of capsaicin by liquid chromatography-tandem mass spectrometry assay and application to oral absorption study. Acta Chromatographica. 2013;25(2):363-376.
논문 70
Kim HJ, Kim TH, Seo WS, Yoo SD, Kim IH, Joo SH, Shin S, Park ES, Ma ES, Shin BS. Pharmacokinetics and tissue distribution of psammaplin A, a novel anticancer agent, in mice. Arch Pharm Res. 2012;35(10):1849-1854.
논문 71
Shin BS, Kim TH, Paik SH, Chi YH, Lee JH, Tan HK, Choi Y, Kim M, Yoo SD. Simultaneous determination of fimasartan, a novel antihypertensive agent, and its active metabolite in rat plasma by liquid chromatography-tandem mass spectrometry. Biomed Chromatogr. 2011;25(11):1208-1214.
